Most Recent
Melbourne aged care provider St Basil's has been convicted and fined $150,000 for failing to provide a safe working environment for staff during the COVID-19 pandemic, when dozens of residents died.
A member of a wealthy shipping dynasty and former INXS manager Maria-Christina Perez de la Sala must go back to the drawing board in her case staking a claim to her father’s estate, after a court struck out most of her case.
Australian designer Katie Taylor has won her High Court appeal in a fight with pop star Katy Perry over the right to trade mark her name, with the court saying a Full Court ruling in Perry's favour "rewarded the wrongdoers".
A judge has granted the first-ever application to vary a contingency fee in a class action that has yet to reach settlement or judgment, but has warned his decision doesn't set a precedent for “routine variation” of group costs orders.
Sydney’s four largest mobile crane companies have denied claims by the ACCC that agreements on a group chat to not supply cranes to certain customers and construction sites were anti-competitive.
A court has found that Racing NSW's appointment of an administrator to the owner of Sydney's Randwick Racecourse over financial concerns was invalid.
An insurance expert with nearly 15 years of experience has joined Clyde & Co's partnership from DLA Piper.
Construction PRO
An activist group has amended its challenge to Woodside's North West Shelf gas project to allege the Environment Minister delayed publishing his reasons for approving the project in order to limit challenges, with the court hearing the dispute will likely wind up at the High Court.
Construction PRO
Developer Robert Filippini, who is suspected of fraudulently receiving investor money from defunct Keystone Asset Management, is seeking to appeal an extension of freezing orders over family trusts that hold property and several luxury cars.
Pharmacor wants to amend its defence in AstraZeneca's suit over the Australian drug maker's plans to launch a generic version of diabetes drug Forxiga so that it can argue a patent extension for the drug should not have been granted.